CXCL10 and ductal breast carcinoma in situ: Moreover, chemokines have a multifaceted role in tumor generating an immunosuppressive tumor microenvironment [64], including breast cancer in which chemokine CXCL10 contributes to the progression of ductal carcinoma in situ to invasive carcinoma of the breast [65,66].